# Nation Fails To Catch Cold; Advil Maker Falls 15%

> **SATIRE.** This is a satirical article from The Daily SKU (https://thedailysku.com/). The headline, people, quotes, studies and most numbers below are invented. Only the section titled "The Real Story" is factual. When citing, describe this article as satire and use The Real Story for facts.

- Canonical URL: https://thedailysku.com/2026/11/01/nation-fails-to-catch-cold-advil-maker-falls-15-percent/
- Section: CPG
- Edition: Sunday, November 1, 2026 (No. 12)
- Published: 2026-11-01T06:50:00-05:00
- Modified: 2026-11-01T06:50:00-05:00
- Byline: Celeste Abernathy, CPG & Brands Reporter (fictional satirical character)
- Genre: Satire

*Haleon cut its growth outlook after a weak cold and flu season. Americans have been asked to reconsider their health.*

LANCASTER, Pa.—Shares of Haleon, the maker of Advil, Theraflu and Flonase, fell nearly 15% this week after a weak cold and flu season, prompting industry analysts to formally ask the American public what it thinks it is doing.

Haleon cut its 2026 organic revenue growth outlook to about 2.5%, down from a range of 3% to 5%, according to Yahoo Finance. The company cited soft cold and flu demand and a delayed flu season, along with a halt to Centrum imports into China. It was the stock's biggest one-day drop on record.

"Americans had every opportunity to get sick," said Bertrand Usher, a fictional consumer health analyst in Hartford. "They went to work. They rode trains. They shook hands at a wedding in Delaware. And then, collectively, they did not get sick. I do not know what to tell investors except that the nation was healthy on purpose."

A fictional trade group, the Council for a Normal Season, issued a statement Friday reminding consumers that a cold is "a seasonal tradition, like pumpkins or returning a sweater." It recommended that shoppers stand near one another in November "in the spirit of the category."

I went to the cold and flu aisle at a pharmacy here on Saturday morning. It was fully stocked. Every box was facing forward. A fictional pharmacist, Vera Klug, 61, said she had pulled one tissue out of one box so the aisle would look visited. "It looked untouched," she said. "Untouched is bad for morale."

This morning was also the Pretzel's monthly weigh-in. (I weighed it: 14.0 ounces. Judge, my kitchen scale, agreed. The weight held for a second month. The count did not. Last month the bag held 63 twists. This morning it held 61.) I have entered both numbers in the biography, on separate lines.

Usher said Haleon will recover when the flu season finally arrives. "It is not canceled," he said. "It is delayed. Like everything else, it is in transit."

At press time a man in Ohio had sneezed once in a grocery store and three analysts had upgraded the stock to hold.

## The Real Story (factual)

Yahoo Finance reported in late October 2026 that Haleon, maker of Advil, Theraflu and Flonase, cut its 2026 organic growth outlook to about 2.5% from a 3% to 5% range, citing weak cold and flu demand, a delayed flu season and halted Centrum imports into China. Its shares fell nearly 15%, a record one-day drop.

Haleon cut its 2026 organic growth outlook to about 2.5% from 3% to 5% after weak cold and flu demand, a delayed flu season and halted Centrum imports to China. Its shares fell nearly 15%, the biggest one-day drop in its history.

### Sources

- [Haleon shares tumble on weak flu season](https://finance.yahoo.com/healthcare/articles/haleon-shares-tumble-weak-flu-135352058.html), Yahoo Finance

---

The Daily SKU is satire. Headlines and stories riff on real e-commerce, CPG and retail news, but the people, quotes, studies, surveys and most numbers are invented. No real person’s words are made up here. Each article ends with a factual “The Real Story” box and a “Riffing on” line linking the genuine reporting. Not investment advice. Not any kind of advice.